User:Whispyhistory/library/pharmacology
Jump to navigation
Jump to search
Books
- ref name=BNF82"xx". British National Formulary (BNF) (82 ed.). BMJ Group and the Pharmaceutical Press. September 2021 – March 2022. pp. xxx. ISBN 978-0-85711-413-6.
{{cite book}}
: CS1 maint: date format (link) - Hitchings, Andrew; Lonsdale, Dagan; Burrage, Daniel; Baker, Emma (2019). The Top 100 Drugs: Clinical Pharmacology and Practical Prescribing (2nd ed.). Elsevier. ISBN 978-0-7020-7442-4.
- xxx, xxx; xxx, xxx (2020). "xxx". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology 15e. New York: McGraw-Hill. pp. x–y. ISBN 978-1-260-45231-0.
- Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Rang, Humphrey P. (2020). Rang & Dale's Pharmacology. Elsevier. ISBN 978-0-7020-7448-6.
Rang & Dale's (2024)
- Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Robinson, Emma; Fullerton, James (2024). "xx". Rang & Dale's Pharmacology (10th ed.). Elsevier. pp. xx. ISBN 978-0-7020-7448-6.
- Antibiotics[1]
BNF86 2023
- "xx". BNF 86: September 2023 - March 2024. BMJ Group and the Pharmaceutical Press. 2023. p. xx. ISBN 978-0857114617.
- p. 254 Metolazone - exercise precaution when switching
- p. 594 Azithromycin dose changes
BNF85 2023
- BNF 85: March-September 2023. BMJ Group and the Pharmaceutical Press. 2023. p. 1079. ISBN 978-0857114587.
- p.1140 Anagrelide - risk of thrombosis due to rebound rise in platelets if stopped suddenly.
- p.952 daratumumab - Avoid in pregnancy and breast feeding. Contraception til 3 months after stopping.
- p.744 Denosumab - risk of hypercalcaemia in age under 18 years
- p.936 Ozanimod
BNF84 2022/2023
Changes to previously
- p. 112 Amiodarone - need for monitoring
- p. 132 antiplatelet drugs for transcatheter aortic valve implantation
- P. 1396 - BCG for neonates
- P. 1280 - Brolucizumab
- P. 480 - Buprenorphine guidance
- P. 853 - chlorhexidine primary area now genitourinary and secondary mouth
- P. 853 - chloroquine increased risk of CV events when used with macrolide ABs
- P. 981 - cladribine liver injury advice
- p. 1179 - colecalciferol max dose
- p. 1452 - esketamine - register
- p. 761 metformin safety in pregnancy
- 1. Gastro-intestinal system
- 2. Cardiovascular system
- 3. Respiratory system
- 4. Nervous system [2]
- 5. Infection[3]
- 6. Endocrine system
- 7. Genito-urinary system
- 8. Immune system and malignant disease
- 10. Musculoskeletal system
- 12. Ear, nose and oropharynx
- 14. Vaccines
- 15. Anaesthesia
- 16. Emergency treatment of poisoning
Children
- Vaccines: [4]
Basic & Clinical Pharmacology (2021)
- 11. Antihypertensives[5]
- 22. Sedative - Hypnotic drugs[6]
- 13. Drugs used in heart failure[7]
- 15. Diuretic agents[8]
- 24. Antiseizure drugs[9]
- 36. Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics, & drugs used in gout[10]
- 43. Beta-lactam and other cell wall - & membrane - active antibiotics[11]
- 48. Antifungal agents[12]
- 61. Dermatologic pharmacology[13]
- 62. Drugs used in the treatment of gastrointestinal diseases[14]
- 65. Dietary supplements & herbal medicines[15]
- Appendix: Vaccines, immune globulins, and other complex biologic products[16]
Independent and Supplementary Prescribing: An Essential Guide (2022)
- Chapter 8c. Renal impairment[17]
- Chapter 11. Extended/Supplementary Prescribing: A Public health Perspective[18]
Rang & Dale's (2020)
- 14. Cholinergic transmission[19]
- 28. Skin[20]
- 29. Respiratory system[21]
- 30. The kidney and urinary system[22]
- 45. Anxiolytic and hypnotic drugs[23]
- 46. Antiepileptic drugs[24]
- 47. Antipsychotic drugs[25]
- 48. Antidepressant drugs[26]
- 49. Psychoactive drugs[27]
- 52. Antibacterial drugs[28]
- 54. Antifungal drugs[29]
Other books
- Top 100 drugs (2022)[30]
General review pages
See also
References
- ↑ Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Robinson, Emma; Fullerton, James (2024). "52. Antibacterial drugs". Rang & Dale's Pharmacology (10th ed.). Elsevier. pp. 707–720. ISBN 978-0-7020-7448-6.
- ↑ "4. Nervous system". BNF (84 ed.). London: BMJ Group and the Pharmaceutical Press. September 2022 – March 2023. pp. 325–539. ISBN 978-0-85711-432-7.
{{cite book}}
: CS1 maint: date format (link) - ↑ "5. Infection". BNF (84 ed.). London: BMJ Group and the Pharmaceutical Press. September 2022 – March 2023. pp. 540–720. ISBN 978-0-85711-432-7.
{{cite book}}
: CS1 maint: date format (link) - ↑ "14. Vaccines". BNF for children (84 ed.). London: BMJ Group and the Pharmaceutical Press. September 2022 – March 2023. pp. 865–913. ISBN 978-0-85711-428-0.
{{cite book}}
: CS1 maint: date format (link) - ↑ Benowitz, Neal L. (2020). "11. Antihypertensive agents". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. pp. 177–198. ISBN 978-1-260-45231-0.
- ↑ Trevor, Anthony J. (2020). "22. Sedative - Hypnotic drugs". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. pp. 395–409. ISBN 978-1-260-45231-0.
- ↑ Benowitz, Neal L. (2020). "13. Drugs used in heart failure". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. pp. 218–234. ISBN 978-1-260-45231-0.
- ↑ Sam, Ramin; Pearce, David (2020). "15. Diuretic agents". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. pp. 262–284. ISBN 978-1-260-45231-0.
- ↑ Rogawski, Michael A. (2020). "24. Antiseizure drugs". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. pp. 422–455. ISBN 978-1-260-45231-0.
- ↑ Shagroni, T.; Cazares, Ramirez; Kim, J. A.; Furst, Daniel E. (2020). "36. Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics, & drugs used in gout". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. pp. 666–690. ISBN 978-1-260-45231-0.
- ↑ Beauduy, Camille E.; Winston, Lisa G. (2020). "43. Beta-lactam and other cell wall - & membrane - active antibiotics". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. pp. 823–843. ISBN 978-1-260-45231-0.
- ↑ Lampiris, Henry W.; Maddix, Daniel S. (2020). "48. Antifungal agents". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. pp. 887–896. ISBN 978-1-260-45231-0.
- ↑ Robertson, Dirk B.; Maibach, Howard I. (2020). "61. Dermatologic pharmacology". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. pp. 1129–11129. ISBN 978-1-260-45231-0.
- ↑ McQuaid, Kenneth R. (2020). "62. Drugs used in the treatment of gastrointestinal diseases". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. pp. 1130–1167. ISBN 978-1-260-45231-0.
- ↑ Dennehy, Cathi E.; Tsourounis, Candy (2020). "65. Dietary supplements & herbal medicines". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. pp. 1179–1194. ISBN 978-1-260-45231-0.
- ↑ Lampiris, Harry W.; maddix, Daniel S. (2020). "Appendix: Vaccines, immune globulins, and other complex biologic products". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. pp. 1227-1234}. ISBN 978-1-260-45231-0.
- ↑ Haslam, Sally J. (2022). "8c. Renal impairment". In Courtenay, Molly; Griffiths, Matthew (eds.). Independent and Supplementary Prescribing: An Essential Guide (Third ed.). Cambridge: Cambridge University Press. p. 146. ISBN 978-1-108-92851-9.
- ↑ Courtenay, Molly; Griffiths, Matthew, eds. (2022). "11. Extended/Supplementary Prescribing: A Public health Perspective". Independent and Supplementary Prescribing: An Essential Guide (Third ed.). Cambridge: Cambridge University Press. pp. 210–214. ISBN 978-1-108-92851-9.
- ↑ Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Rang, Humphrey P. (2020). "14. Cholinergic transmission". Rang & Dale's Pharmacology (9th ed.). Elsevier. pp. 175–196. ISBN 978-0-7020-7448-6.
- ↑ Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Rang, Humphrey P. (2020). "28. Skin". Rang & Dale's Pharmacology (9th ed.). Elsevier. pp. 362–368. ISBN 978-0-7020-7448-6.
- ↑ Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Rang, Humphrey P. (2020). "29. Respiratory system". Rang & Dale's Pharmacology (9th ed.). Elsevier. pp. 371–381. ISBN 978-0-7020-7448-6.
- ↑ Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Rang, Humphrey P. (2020). "30. The kidney and urinary system". Rang & Dale's Pharmacology (9th ed.). Elsevier. pp. 382–394. ISBN 978-0-7020-7448-6.
- ↑ Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Rang, Humphrey P. (2020). "45.Anxiolytic and hypnotic drugs". Rang & Dale's Pharmacology (9th ed.). Elsevier. pp. 569–579. ISBN 978-0-7020-7448-6.
- ↑ Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Rang, Humphrey P. (2020). "46. Antiepileptic drugs". Rang & Dale's Pharmacology (9th ed.). Elsevier. pp. 580–591. ISBN 978-0-7020-7448-6.
- ↑ Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Rang, Humphrey P. (2020). "47. Antipsychotic drugs". Rang & Dale's Pharmacology (9th ed.). Elsevier. pp. 592–602. ISBN 978-0-7020-7448-6.
- ↑ Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Rang, Humphrey P. (2020). "48. Antidepressant drugs". Rang & Dale's Pharmacology (9th ed.). Elsevier. pp. 603–622. ISBN 978-0-7020-7448-6.
- ↑ Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Rang, Humphrey P. (2020). "49. Psychoactive drugs". Rang & Dale's Pharmacology (9th ed.). Elsevier. pp. 623–641. ISBN 978-0-7020-7448-6.
- ↑ Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Rang, Humphrey P. (2020). "52. Antibacterial drugs". Rang & Dale's Pharmacology (9th ed.). Elsevier. pp. 661–677. ISBN 978-0-7020-7448-6.
- ↑ Ritter, James M.; Flower, Rod; Henderson, Graeme; Loke, Yoon Kong; Rang, Humphrey P. (2020). "54. Antifungal drugs". Rang & Dale's Pharmacology (9th ed.). Elsevier. pp. 690–695. ISBN 978-0-7020-7448-6.
- ↑ Hitchings, Andrew; Lonsdale, Dagan; Burrage, Daniel; Baker, Emma (2022). "xx". The Top 100 Drugs (3rd ed.). Elsevier Health Sciences. p. 1. ISBN 978-0-323-83445-2.
- ↑ "A - Z Drug List from Drugs.com". Drugs.com. American Society of Health-System Pharmacists. Retrieved 20 November 2021.
- ↑ "Non-Opioid Analgesics Role in Pain Management". NEJM Knowledge+. 19 December 2019.